121 related articles for article (PubMed ID: 23303003)
1. Chronic lymphocytic leukemia.
Kriachok IA
Exp Oncol; 2012 Dec; 34(4):378-80. PubMed ID: 23303003
[No Abstract] [Full Text] [Related]
2. Current results and prospective trials of cladribine in chronic lymphocytic leukemia.
Tallman MS; Hakimian D
Semin Hematol; 1996 Jan; 33(1 Suppl 1):23-7. PubMed ID: 8714613
[No Abstract] [Full Text] [Related]
3. New agents in early clinical trials for CLL therapy.
Furman RR
Clin Adv Hematol Oncol; 2010 Jul; 8(7):475-6. PubMed ID: 20864914
[No Abstract] [Full Text] [Related]
4. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
Saven A
Semin Hematol; 1996 Jan; 33(1 Suppl 1):28-33. PubMed ID: 8714614
[No Abstract] [Full Text] [Related]
5. Fludarabine.
Med Lett Drugs Ther; 1991 Sep; 33(853):89-90. PubMed ID: 1886506
[No Abstract] [Full Text] [Related]
6. Current status and future directions of clinical trials in chronic lymphocytic leukemia.
Nerenstone SR; Archer JI; Cheson BD
Oncology (Williston Park); 1987 Oct; 1(8):31-40, 44. PubMed ID: 3079490
[TBL] [Abstract][Full Text] [Related]
7. Purine analogs in the treatment of chronic lymphocytic leukemia.
Pott C; Hiddemann W
Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
[TBL] [Abstract][Full Text] [Related]
8. Idelalisib for chronic lymphocytic leukemia.
Brown JR
Clin Adv Hematol Oncol; 2014 Dec; 12(12):846-8. PubMed ID: 25674842
[No Abstract] [Full Text] [Related]
9. Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation.
Cheson BD
Semin Hematol; 1998 Jul; 35(3 Suppl 3):14-21. PubMed ID: 9685175
[No Abstract] [Full Text] [Related]
10. Recent developments in the treatment of CLL.
Cheson BD
Clin Adv Hematol Oncol; 2008 May; 6(5):6-8; quiz 10-2. PubMed ID: 18578096
[No Abstract] [Full Text] [Related]
11. Chronic lymphocytic leukaemia. Current strategy and new perspectives of treatment.
Rai KR
Haematologica; 1999 Jun; 84 Suppl EHA-4():94-5. PubMed ID: 10907481
[No Abstract] [Full Text] [Related]
12. Alemtuzumab in chronic lymphocytic leukemia.
James DF; Kipps TJ
Future Oncol; 2007 Feb; 3(1):29-42. PubMed ID: 17280499
[TBL] [Abstract][Full Text] [Related]
13. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
Rai KR
Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
Byrd JC; Lin TS; Grever MR
Semin Oncol; 2006 Apr; 33(2):210-9. PubMed ID: 16616068
[TBL] [Abstract][Full Text] [Related]
15. Advances in the use of alemtuzumab in CLL.
Stilgenbauer S
Clin Adv Hematol Oncol; 2008 Jan; 6(1):23-4. PubMed ID: 18322437
[No Abstract] [Full Text] [Related]
16. Bendamustine in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Ujjani C; Cheson BD
Expert Rev Anticancer Ther; 2010 Sep; 10(9):1353-65. PubMed ID: 20836669
[TBL] [Abstract][Full Text] [Related]
17. Initial therapy for patients with chronic lymphocytic leukemia.
Wierda WG; O'Brien SM
Semin Oncol; 2006 Apr; 33(2):202-9. PubMed ID: 16616067
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia: where are we and where are we going?
Ujjani C; Cheson BD
Expert Opin Pharmacother; 2012 Aug; 13(12):1675-7. PubMed ID: 22768797
[No Abstract] [Full Text] [Related]
19. B-cell receptor inhibitors in chronic lymphocytic leukemia.
Brown JR
Clin Adv Hematol Oncol; 2013 Jun; 11(6):362-4. PubMed ID: 24472805
[No Abstract] [Full Text] [Related]
20. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
